ConductScience.org, home

Gene · 11126

CD160: CD160 molecule

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CD160: CD160 molecule. Genes, record 11126. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11126

On this page

Gene

Symbol
CD160
HGNC
Name
CD160 molecule
HGNC
NCBI Gene ID
11126
NCBI Gene
HGNC ID
HGNC:17013
HGNC
Ensembl
ENSG00000117281
NCBI Gene
Aliases
BY55, NK1, NK28
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O95971CD160 antigen1814Ensembl, GeneID, HGNC

Source UniProt

Patents104

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4806462 A22026-09-1641O95971Espacenet
EP 4641202 A22025-10-294393O95971Espacenet
JP 2025147176 A2025-10-062218O95971Espacenet
JP 2025147176 A2025-10-062219O95971Espacenet
JP 2025147176 A2025-10-0614659O95971Espacenet
EP 4619424 A22025-09-2410O95971Espacenet
JP 2025529142 A2025-09-045764O95971Espacenet
US 12371689 B22025-07-295764O95971Espacenet
JP 2025028160 A2025-02-282218O95971Espacenet
JP 2025028160 A2025-02-282219O95971Espacenet

1 to 10 of 104

See all 104 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,312

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCD160 papersNewest fiscal year
U19AI082630Durable Alteration of the Human Immune system after Infection or Immunotherapy192025
P30CA008748Cancer Center Support Grant122025
P30CA016672Cancer Center Support Grant112025
P01AI039671Costimulatory Mechanisms of Autoimmunity92025
P01AI108545Synergies among inhibitory receptors in tolerance and disease92025
P51OD011132Emory National Primate Research Center72025
P30AI027763UCSF-Bay Area Center for AIDS Research62025
P30AI027767UAB Center for AIDS Research (CFAR)62025
P30CA016058Cancer Center Support Grant62025
P50CA121974Yale SPORE in Skin Cancer62025

1 to 10 of 1,312Source NIH's project files

See all 1,312 nih grants

Papers2,063

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Mutant HVEM in lymphoma disrupts BTLA and CD160 regulation of anti-tumor signaling.Front Immunol202642798506PubTator, text miningPubMed
Pre-treatment T-cell Transcriptional Signatures Predict Immunotherapy Outcomes in Melanoma.Res Sq202642687902PubTator, text miningPubMed
Proteomic Insights Into Human Induced Regulatory T Cells: The Role of LPXN and CD160 in Immune Suppression.Mol Cell Proteomics202642624209PubTator, text miningPubMed
Immune dysregulation and exhaustion in EBV- associated hemophagocytic lymphohistiocytosis: insights from single-cell transcriptomics and TCR repertoire analysis.Front Immunol202642620862PubTator, text miningPubMed
Ovarian Cancer-Associated Ascites Accumulates NK Lymphocytes Displaying a Transcriptomic Profile Consistent With the Immature/Secretory CD56bright Subtype.Immunol Cell Biol202642619603PubTator, text miningPubMed
Anti-4CB1: A Novel Selective HVEM-Blocking Antibody Enhancing T-Cell and Macrophage Immunity Against Solid Tumors.Mol Cancer Ther202642617197PubTator, text miningPubMed
CD244 overexpression indicates NK cell dysfunction and tumor progression in diffuse large B-cell lymphoma.Front Immunol202642483169PubTator, text miningPubMed
KIF7 promotes the proliferation of clear cell renal cell carcinoma by activating the WNT/β-catenin signaling pathway.Clin Exp Med202642366250PubTator, text miningPubMed
An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer.Front Oncol202642339115PubTator, text miningPubMed
Polymorphisms in immune checkpoint genes might influence bladder cancer risk and clinical outcome.Hum Immunol202642284619PubTator, text miningPubMed

1 to 10 of 2,063

See all 2,063 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/11126

GET https://conductscience.org/api/genes/v1/11126/patents?page=2